Abstract:Background:Depression is a kind of chronic and recurrent mental disorder, the main clinical characteristics of the patients are marked and persistent depression. At the same time, it is often accompanied by chronic physical disease, cognitive impairment, and functional damage, which is one of the common diseases that seriously threaten human health. At present, 3 kinds of oral Chinese patent medicine have clinical comparability in the treatment of depression of liver stagnation and spleen deficiency, but there is no evidence for clinical efficacy and safety. Therefore, this study aims to integrate the clinical related syndromes of direct and indirect comparison by using systematic evaluation and network meta-analysis (NMA). According to the data, the different Chinese patent medicines with the same evidence body for the treatment of the disease are collected, analyzed, and sequenced in a quantitative and comprehensive way, and then the advantages and disadvantages of the efficacy and safety between different Chinese patent medicines are screened out to get the best choice scheme, thus providing reference value and evidence-based theoretical evidence for the clinical optimization of drug selection.Methods:Comprehensive retrieval of China National Knowledge Infrastructure, Chinese scientific journal database (VIP), China biological feature database (CBM) and WANFANG Data Chinese electronic database and the Cochrane Library, PubMed, Web of Science, and EMBASE foreign database. Search and publish the clinical randomized controlled trials of these 3 Chinese patent medicines combined with fluoxetine compared with fluoxetine. The retrieval time is from the establishment of the database to October 31, 2019. The 2 first authors will screen the literatures that meet the inclusion criteria, extract the data independently according to the predesigned rules, and evaluate the literature quality and bias risk of the included research according to the Cochrane 5.1 manual standard. R and Aggregate Data Drug Information System software were used for data consolidation and NMA to evaluate the ranking probability of all interventions.Results:This result will show that the best oral Chinese patent medicine to assist the treatment of liver stagnation and spleen deficiency depression provides reliable evidence.Conclusion:This study will provide systematic evidence-based medicine evidence for TCM assisted treatment of depression of liver stagnation and spleen deficiency type, and help clinicians, patients with depression and decision-makers to make more effective, safer, and economic optimal treatment plan in the decision-making process.PROSPERO registration number:CRD42019115695.

A Traditional Chinese Medicine Approach in Treating Depression by Promoting Liver Qi Circulation: A Western Medicine Perspective

Pathogenesis of depression and the potential for traditional Chinese medicine treatment

Traditional Chinese Medicine in Depression Treatment: From Molecules to Systems

Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics

Progress of research on the treatment of depression by traditional Chinese medicine prescriptions

Antidepressant mechanism of traditional Chinese medicine: Involving regulation of circadian clock genes

Acupuncture driven depression treatment: a noninvasive approach with acupuncture and oriental medication

Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: Efficacies and mechanisms

[Traditional Chinese medicine prevents and treats depression by regulating hippocampal neuroplasticity: a review]

Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression

Prescription of Chinese Herbal Medicine in Pattern-Based Traditional Chinese Medicine Treatment for Depression: A Systematic Review

Professor Wang Yali’s Experience in Treating Depression Based on the Theory of "liver Yin in Physique and Yang in Function"

Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment

Exploring the transformative impact of traditional Chinese medicine on depression: Insights from animal models

Chinese Herbal Medicine for the Treatment of Depression: Applications, Efficacies and Mechanisms.

The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity

Prevention and treatment of natural products from Traditional Chinese Medicine in depression: Potential targets and mechanisms of action

The clinical application of Chinese herbal medication to depression: A narrative review

Chinese Herbal Medicine for the Treatment of Depression: Effects on the Neuroendocrine-Immune Network

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.